Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Annexon | ANNX | Nov 12, 2024 | 6.61 | -5.17 |
Annovis Bio | ANVS | Nov 12, 2024 | 7.54 | -1.44 |
ANSYS | ANSS | Nov 12, 2024 | 344.48 | -0.53 |
Antelope Enterprise | AEHL | Nov 12, 2024 | 0.30 | -2.26 |
Anterix | ATEX | Nov 12, 2024 | 33.78 | -2.29 |
Antero Midstream | AM | Nov 12, 2024 | 15.41 | -1.22 |
Antero Resources | AR | Nov 12, 2024 | 31.16 | -1.61 |
Anywhere Real Estate | HOUS | Nov 12, 2024 | 3.83 | -3.28 |
Aon | AON | Nov 12, 2024 | 383.66 | +0.07 |
APA | APA | Nov 12, 2024 | 21.87 | -1.35 |
Apartment Investment and Management | AIV | Nov 12, 2024 | 8.61 | -0.58 |
Apellis Pharmaceuticals | APLS | Nov 12, 2024 | 29.26 | -1.08 |
APi Group | APG | Nov 12, 2024 | 36.96 | +0.24 |
Apogee Enterprises | APOG | Nov 12, 2024 | 85.25 | -2.26 |
Apogee Therapeutics | APGE | Nov 12, 2024 | 57.35 | -5.14 |
Apollo Commercial Real Estate Finance | ARI | Nov 12, 2024 | 9.08 | -1.94 |
Apollo Global Management | APO | Nov 12, 2024 | 163.75 | -1.80 |
Apollomics A | APLM | Nov 12, 2024 | 0.12 | -0.17 |
AppFolio A | APPF | Nov 12, 2024 | 235.26 | +0.77 |
Appian A | APPN | Nov 12, 2024 | 39.96 | -0.79 |
Apple | AAPL | Nov 12, 2024 | 224.23 | 0.00 |
Apple Hospitality REIT | APLE | Nov 12, 2024 | 15.90 | -0.56 |
Applied Digital | APLD | Nov 12, 2024 | 7.59 | +0.13 |
Applied DNA Sciences | APDN | Nov 12, 2024 | 0.19 | +0.38 |
Applied Industrial Technologies | AIT | Nov 12, 2024 | 273.88 | -0.48 |
Applied Materials | AMAT | Nov 12, 2024 | 186.61 | -1.03 |
Applied Optoelectronics | AAOI | Nov 12, 2024 | 28.54 | +0.88 |
Applied Therapeutics | APLT | Nov 12, 2024 | 9.90 | -3.32 |
Applovin A | APP | Nov 12, 2024 | 289.03 | +0.91 |
AppTech Payments | APCX | Nov 12, 2024 | 0.66 | +0.15 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.